Calimbang, Jurelyn M.

HRN: 16-80-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/25/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/25/2026
07/02/2026
IV
215mg
Q8H
Ruptured Appendicitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines